Adenovirus vector expressing human interleukin-12 (hIL-12)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adenovirus vector expressing human interleukin-12 (hIL-12), covering 2025-10-29 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat Melanoma [Phase 1, Phase 2]